Aggressive Behavior of Low-Grade Ta Papillary Urothelial Bladder Neoplasm in a 17-Year-Old Patient

Urology

Volumn 69, Issue 5, 2007, Pages 983.e1-983.e2

  Labanaris, Apostolos P ^a,b   Labanaris, Panagiotis G ^b   Gitsos, Giorgos ^b   Kühn, Reinhard ^a   Schott, Ghünter E ^c   Zugor, Vahudin ^c  

^a Academic Hospital   (Germany)

^b INTERBALKAN MEDICAL CENTER   (Greece)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADOLESCENT; AGGRESSION; ANAMNESIS; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CASE REPORT; CAUTERIZATION; CLINICAL FEATURE; CYSTECTOMY; CYSTOSCOPY; DESTRUCTION; DISEASE ASSOCIATION; ECHOGRAPHY; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; IRRITABILITY; LYMPHADENECTOMY; MALE; MULTIPLE CYCLE TREATMENT; PAPILLOMA; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; URINARY DIVERSION; UROGENITAL TRACT CANCER;

EID: 34247570871     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.02.022     Document Type: Article

References (10)

1. Keetch D.W., Manley C.B., and Catolona W.J. Transitional cell carcinoma of bladder in children and adolescents. Urology 42 (1993) 447-449
2. Yusim I., Lismer L., Greenberg G., et al. Carcinoma of the bladder in patients under 25 years of age. Scand J Urol Nephrol 30 (1996) 461-463
3. Jimenez R.E., Gheiler E., Oskanian P., et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 24 (2000) 980-987
4. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J Urol 130 (1983) 1083-1086
5. Lippenon P. The changing important of prognostic factors in bladder cancer during a long-term follow up. Eur J Cancer 29A (1993) 1261-1265
6. Abel P.D. Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: the case for a change in policy. Br J Urol 72 (1993) 135-142
7. Lamm D.L. Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am 19: (1992) 565-572
8. Berry D.L., Blumenstein B.A., Magyary D.L., et al. Local toxicity patterns associated with intravesical bacillus Calmette-Guérin: a Southwest Oncology Group study. Int J Urol 3 (1995) 98-101
9. Amling C., Thraser J., Frazier H., et al. Radical cystectomy for stages Ta, Tis, and T1 transitional cell carcinoma of the bladder. J Urol 151 (1994) 31-35
10. Freeman J.A., Esrig D., Stein J.P., et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76 (1995) 833-839